R3 Bio Develops Headless Human Bodyoids for Organ Farming and Testing - Ground News
Why it matters: R3 Bio's development could revolutionize organ transplantation and drug development for thousands of patients.
- R3 Bio is developing "bodyoids," which are headless human organisms, for the purpose of organ farming and testing, as reported by Ground News.
- MIT Technology Review uncovered the stealthy startup's pitch for these brainless human clones, adding detail to the company's ambitious goals.
- The Times of India emphasizes the controversial nature of R3 Bio's work, quoting the company's internal slogan, 'No brain, no limits,' in reference to growing these headless human bodies.
R3 Bio, a stealthy, billionaire-backed startup, is developing "bodyoids"—headless human organisms—for organ farming and drug testing, a move described by The Times of India as having "no brain, no limits." MIT Technology Review reveals the company's pitch for these brainless human clones, highlighting the ethical and scientific implications of creating such entities.
